Welcome to our dedicated page for Byrna Technologies SEC filings (Ticker: BYRN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
When you research a company built around less-lethal defense technology, you need more than a document dump—you need clarity. Investors exploring Byrna Technologies insider trading Form 4 transactions often start by asking, “Did executives buy shares ahead of new product launches?” or “How serious are the export-license risks in the latest 8-K material events?”
Our SEC filings hub answers those questions in one place. Real-time notifications surface every Byrna Technologies Form 4 insider transactions real-time alert, while AI-powered summaries turn dense paragraphs into plain English. Want the numbers? The Byrna Technologies quarterly earnings report 10-Q filing is paired with interactive tables and trend lines, so you can compare margins across CO2 cartridge, launcher, and accessory segments without scrolling through footnotes.
Use cases include:
- Spotting shifts in direct-to-consumer revenue inside the Byrna Technologies annual report 10-K simplified
- Tracking leadership pay with the Byrna Technologies proxy statement executive compensation breakdown
- Assessing litigation updates via Byrna Technologies 8-K material events explained
GSK plc filed a Form 6-K reporting routine activity under its June 2025 share buy-back mandate. Acting through its broker Merrill Lynch International, the company repurchased 482,114 ordinary shares (nominal value 31 ¼ p) on 27 June 2025.
Key trade metrics reported for the London Stock Exchange (XLON):
- Price range: 1,395.50 p – 1,410.50 p
- Volume-weighted average price (VWAP): 1,402.45 p
The shares will be held in treasury. Since launching the non-discretionary agreement with the broker on 4 June 2025, GSK has bought back a cumulative 7,554,354 shares.
Post-transaction, GSK’s capital structure is as follows:
- Treasury shares: 225,688,737
- Shares outstanding (excluding treasury): 4,089,681,462
- Total voting rights in issue: 4,089,681,462
- Treasury shares as a percentage of voting rights: 5.52 %
The filing also provides a full schedule of individual XLON trades and confirms no purchases occurred on CBOE venues (CHIX or BATE) on the reporting date.
Byrna Technologies has filed a DEFA14A (Additional Proxy Soliciting Materials) to correct errors in the proxy card attached to their previously filed definitive proxy statement for the 2025 Annual Meeting of Stockholders scheduled for July 29, 2025.
The corrections address three specific errors in the EDGAR filing's proxy card:
- An incorrect meeting date
- Reference to an equity plan proposal that is not being considered at the meeting
- An incorrect fiscal year cited in the auditor ratification proposal
The company emphasizes that this supplement is purely administrative in nature, solely correcting the form of proxy card in the EDGAR version. No other changes have been made to the original proxy statement, and stockholders have been provided with the correct proxy card. The filing contains no fee requirements and was filed directly by the registrant.
Byrna Technologies Inc. (Nasdaq: BYRN) filed a Form 8-K dated June 19 2025 under Item 7.01 – Regulation FD Disclosure. The sole purpose of the filing is to furnish, not file, an updated investor presentation (Exhibit 99.1) that management may use in future meetings with current and prospective shareholders.
The Company expressly states that the information contained in Item 7.01 and Exhibit 99.1 is not deemed “filed” for purposes of Section 18 of the Securities Exchange Act and will not be incorporated by reference into other SEC filings unless specifically referenced. No financial statements, earnings data, or major transactional details accompany this report.
Key Exhibit:
- 99.1 – Investor Presentation (dated June 19 2025)
There are no other material changes, strategic announcements, or quantitative disclosures in this 8-K beyond the availability of the new presentation.
Byrna Technologies has announced its 2025 Annual Meeting of Stockholders to be held on July 29, 2025. The meeting will address three key proposals: election of five directors, ratification of EisnerAmper LLP as independent auditors, and a non-binding vote on executive compensation.
Key governance highlights include:
- Board Composition: 80% independent directors (4 of 5), with 80% gender or ethnic diversity
- Performance Achievements: Record revenues of over $85 million in fiscal 2024, new partnership with Sportsman's Warehouse, launch of Byrna CL product
- Operational Expansion: Opened new U.S. ammunition facility in Fort Wayne, launched four additional retail stores with shooting ranges
Executive compensation changes include restructuring the long-term incentive program, implementing performance-based equity awards, and expanding the clawback policy. The company has demonstrated growth through enhanced marketing programs, celebrity endorsements, and increased retail presence, while maintaining strong corporate governance practices.
FAQ
What is the current stock price of Byrna Technologies (BYRN)?
What is the market cap of Byrna Technologies (BYRN)?
What is the core business of Byrna Technologies Inc.?
How does Byrna differentiate its products?
Who are the primary customers for Byrna Technologies?
What technologies underpin Byrna's personal defense solutions?
How does Byrna maintain high quality in its products?
What is Byrna's approach to manufacturing and supply chain management?
How does Byrna ensure its products are safe for users?
How does the company position itself within the defense technology market?
